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Abstract
Dwarfism in German shepherd dogs is due to combined pituitary hormone deficiency of unknown genetic cause. We
localized the recessively inherited defect by a genome wide approach to a region on chromosome 9 with a lod score of 9.8.
The region contains LHX3, which codes for a transcription factor essential for pituitary development. Dwarfs have a deletion
of one of six 7 bp repeats in intron 5 of LHX3, reducing the intron size to 68 bp. One dwarf was compound heterozygous for
the deletion and an insertion of an asparagine residue in the DNA-binding homeodomain of LHX3, suggesting involvement
of the gene in the disorder. An exon trapping assay indicated that the shortened intron is not spliced efficiently, probably
because it is too small. We applied bisulfite conversion of cytosine to uracil in RNA followed by RT-PCR to analyze the
splicing products. The aberrantly spliced RNA molecules resulted from either skipping of exon 5 or retention of intron 5. The
same splicing defects were observed in cDNA derived from the pituitary of dwarfs. A survey of similarly mutated introns
suggests that there is a minimal distance requirement between the splice donor and branch site of 50 nucleotides. In
conclusion, a contraction of a DNA repeat in intron 5 of canine LHX3 leads to deficient splicing and is associated with
pituitary dwarfism.
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Introduction
A defect in the differentiation of endocrine cells of the pituitary
gland can lead to isolated or combined pituitary hormone
deficiency (CPHD). Normally, the various cell types of the
adenohypophysis arise in a distinct temporal order from
progenitor cells. The corticotropic cells are the first to differentiate
followed by gonadotropes, thyrotropes, lactotropes and somato-
tropes [1,2]. Several of the transcription factors involved in the
differentiation cascade of the endocrine cells of the pituitary have
been identified [3]. In humans and mice, CPHD is mostly related
to mutations in genes encoding the transcription factors POU1F1
(previously known as PIT1) and PROP1 [4–9]. Mutations in other
genes that cause CPHD are rare.
In dogs, congenital growth hormone deficiency or pituitary
dwarfism is the most striking form of CPHD. This condition is
encountered most often in German shepherd dogs (GSD).
Common clinical manifestations are marked growth retardation,
retention of secondary hairs (puppy coat) with concurrent lack of
primary or guard hairs, and bilateral symmetrical alopecia
(Figure 1) [10]. Pituitary dwarfism in the GSD breed is
characterized by underdevelopment of the pituitary gland and a
combined deficiency of growth hormone, thyroid stimulating
hormone, prolactin, and gonadotropins. In contrast, the secretion
of adrenocorticotropic hormone is unaffected in these animals
[11,12]. Therefore, the genetic defect that leads to pituitary
dwarfism must preclude effective expansion of pituitary stem cells
during or after the differentiation of the corticotropic cells. Should
the basic defect be known, the disorder would be a model for
pituitary dwarfism in man. Involvement of POU1F1 and PROP1 in
canine CPHD has been excluded before [13,14]. We set out to
locate the causative gene by a genome wide linkage analysis. We
found that pituitary dwarfism in GSD is associated with a deletion
of a 7 bp repeat in intron 5 of LHX3, a gene encoding another
important transcription factor involved in pituitary development.
It is demonstrated that this contraction of the intron results in
deficient splicing.
Results
Gene localization
Pituitary dwarfism in GSD is inherited recessively [15]. As is the
case with many recessive traits in dog breeds, all dwarfs were
expected to be homozygous for the same gene defect due to
inbreeding. We started the step-by-step localization of the gene by
linkage analysis of two families with in total three dwarfs, using a
genome wide set of microsatellite markers (Figure S1A and S1B).
There were 49 markers that passed the first selection criterion of
homozygosity of dwarfs A7 and A8 for the same allele and sharing
of at least one copy of this allele by dwarf B3. Of these markers, 21
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markers were heterozygous in only two parents and four markers
were heterozygous in three parents. There was only one marker,
REN177B24 on CFA09, for which all four parents were
heterozygous. The three dwarfs were homozygous for allele 366
of this marker and their analyzed siblings were heterozygous.
Therefore, REN177B24 was the first marker to be analyzed
further according to our selection criteria and all available dwarfs,
parents, and siblings were genotyped with this marker. Three of
the 23 dwarfs were not homozygous for the allele of 366 bp (D15,
F4, F9). Just one out of nine available parents (D9) and one out of
17 normal siblings (D14) were homozygous for this allele. The
homozygous sibling was an offspring of the homozygous parent.
The frequency of the associated 366 bp allele was 94% in the
group of dwarfs, 56% in the parents, and 44% in the siblings.
These results showed that the dwarfism phenotype is strongly
associated with marker REN177B24.
To define the critical region, we selected microsatellite markers
neighboring REN177B24 from the genomic reference DNA
sequence. Markers FH2885, REN256F13, CA1, CA3, CA5,
CA7 and CA8 were found to be polymorphic and were
subsequently used to genotype the study group. This fine-mapping
revealed a genomic region containing three markers, markers CA1
and CA5 at position 51.1 Mb, and marker CA8 at 52.6 Mb of
CFA09, for which all dwarfs were homozygous (Figure S1A–S1F).
The multipoint lod score for linkage between pituitary dwarfism
and the CFA09 region reached a maximum value of 9.8 in the
available family material. The markers REN256F13 at position
49.5 Mb and REN177B24 at 54.1 Mb of CFA09 bordered the
critical region. Respectively seven (D13, D15-17, E26, E28, F9)
and three dwarfs (D15, F4, F9) were heterozygous for these
markers and one dwarf was homozygous for another allele of
REN256F17 (E27). The region contained 137 genes, according to
the annotation of the NCBI, build 2.1 (www.ncbi.nlm.nih.gov/
mapview). One of these genes, at position 52.6 Mb of CFA09,
encoded LHX3, a transcription factor essential for pituitary gland
formation [16,17]. We considered this gene to be the prime
candidate for involvement in GSD dwarfism.
Mutation screening of LHX3
The gene structure of canine LHX3 was deduced from BLAST
comparisons between human cDNA sequences and the genome of
the dog. The intron 5-exon 6 junction was not covered by build
2.1 of the reference DNA sequence. The gap was filled by DNA
sequence analysis of BAC clone RP81-17A4 that carries canine
LHX3 (Figure 2A). We analyzed the DNA sequence of the 7 exons
and the intron boundaries in 4 dwarfs (B3, A8, D13, E22) and did
not detect mutations in comparison to the amended version of the
gene. We noted that intron 5 consists of only 75 bp, is very GC-
rich, and contains 6 imperfect repeats of a 7 bp sequence.
Expansions of DNA repeats of up to 12 bp are potentially
pathogenic [18,19]. We therefore wanted to establish whether the
dwarfism phenotype was associated with expansion of the 7 bp
repeat region in intron 5. We found that DNA fragments
containing the GC-rich intron cannot be PCR-amplified with
standard thermostable DNA polymerases. These fragments could
however be amplified after bisulfite conversion of cytosine residues
to uracil [18]. In addition, these fragments could be amplified with
the use of Platinum pfx DNA polymerase [20]. Surprisingly, the
DNA fragments from dwarfs that contain LHX3 intron 5 were
shorter than the fragments from control dogs. The DNA sequence
showed that the size difference is the result of a deletion of one
7 bp repeat unit from the intron (Figure 2B). All dwarfs except one
(F9), displayed homozygosity for the 7 bp deletion, all available
parents were heterozygous carriers and their siblings were either
carrier or did not have the 7 bp deletion. These relatives included
the 3 parents and 4 siblings that were homozygous like the dwarfs
for allele 243 of marker CA8. This result established that LHX3
was located within the linked region with zero recombination.
Dwarf F9, which was not homozygous for the deletion, was a
compound heterozygote with a second mutation described below.
Seven dogs from a group of 37 unrelated GSD from the Dutch
population with normal growth were carrier of the 7 bp deletion
(allele frequency=0.094).
In vitro splicing assay
We supposed that the mutant size of LHX3 intron 5 of 68
nucleotides (nt) could be too small to be spliced efficiently. We
tested this possibility by applying an exon trapping assay. Cultured
eukaryotic cells were transfected with recombinant plasmids that
carried multiple introns and exons under the control of a promoter
of transcription. The splicing machinery of the host cell processed
the transcript if the proper signals were present and the RNA
products could be characterized by RT-PCR. A pSPL3b-derived
plasmid was constructed that included exon 5, intron 5 and exon 6
of LHX3 derived from BAC RP81-17A4. This construct was used
to create a second plasmid with a 7 bp deletion in intron 5
identical to the mutation in intron 5 of GSD dwarfs (Figure 3A).
COS-7 cells were transfected with either construct or mock
transfected and the transcripts were analyzed using RT-PCR with
primer set I that spanned the first vector derived exon and exon 6.
The products included the fragment expected from normal
splicing (Figure 3B, lanes 2 and 3). In addition, a larger product
was seen with both constructs in which the chimeric intron was
retained. The identity of the products was confirmed by DNA
sequence analysis. A product of approximately 280 bp was
apparent with the mutant construct but hardly detectable with
the construct containing LHX3 intron 5 of normal size. This
fragment was shown by sequence analysis to consist of the first
recombinant exon spliced to exon 6 of LHX3, so it represented
skipping of exon 5 in the splicing process.
Another result that could be expected from a defective intron
would be retention of that intron. A technical problem to detect
Figure 1. Two fourteen-month-old male German shepherd
dogs from the same litter. A healthy German shepherd dog (C8, left)
and his littermate that is affected by pituitary dwarfism (C6, right). Note
the proportionate growth retardation, the retention of puppy hairs and
the lack of guard hairs of the dwarf.
doi:10.1371/journal.pone.0027940.g001
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intron to be amplified by PCR because of the high cytosine content.
Analogous to the resolution of strong base pairing in DNA, strong
base pairing in the cDNA was prevented by treatment of the RNA
with bisulfite prior to cDNA synthesis. The plasmids described
above that contained mutant or normal intron 5 were used again,
but in this experiment the products were analyzed by RT-PCR
primer set II that spanned intron 5 only and had sequences adapted
to the bisulfite conversion. Cells transfected with the plasmid
containing the normal intron produced spliced RNA of the
anticipated size (Figure 3C, lane 1). The same product and a
larger, more prominent product were found in cells transfected with
the mutant construct (Figure 3C, lane 2). The larger product was
derived from RNA that had retained the mutant intron 5. Again,
the identity of the fragments was established by DNA sequence
analysis of the excised bands. These results are consistent with our
supposition that the mutant intron 5 of 68 nt is defective.
LHX3 cDNA analysis
To establish whether the splice defects observed with the exon
trapping assay could be detected in vivo, we analyzed LHX3 cDNA
from the available pituitary glands of two dwarfs (F8 and F9) and
of a normal dog of mixed breed. In addition to normally spliced
products, dwarf cDNA displayed retention of intron 5 in a
proportion of the transcripts with a processed intron 4, and
skipping of exon 5 in another part of the products (Figure 4A).
These splicing products were not seen in the cDNA from the
normal dog. Skipping of exon 5 of 152 nt results in a frame shift
(NP_001184116.1, p.E159fs). The translation product would lack
the highly conserved, DNA-binding homeodomain. Retention of
the mutant intron of 68 nt leads to an insertion of 21 amino acids
and a frameshift at the protein level (p.V208ins21fs). The first
triplets of both intron 5 and exon 6 are valine codons.
Splicing defects are known to induce nonsense-mediated decay
of the RNA [21] and the intron 5 mutation could lead to a low
RNA expression level. Quantitative RT-PCR experiments indi-
cated that the expression of LHX3 in the homozygous dwarf F8
was approximately 100-fold lower than in a normal dog.
Remarkably, one of the two dwarfs (F9) of which the cDNA was
analyzed, showed to be heterozygous for an insertion of an ACA
trinucleotide sequence (Figure 4C). The insertion occurred at a site
of two ACA triplets that are normally present in exon 5
(NM_001197187, c.545_547dupACA). The result for the open
reading frame was an insertion of an AAC codon for asparagine at
position 182 of the LHX3b protein isoform (p.N182dup), which is
located in the first a-helix of the homeodomain of LHX3. The
triplet insertion and the heterozygosity of the dwarf were
confirmed by sequence analysis of exon 5 from genomic DNA
(Figure S2A). The insertion is situated close to intron 5 and can be
amplified as part of the same fragment. The heterozygous dwarf
displayed the fragment with the 7 bp deletion in addition to a
fragment that was 3 bp longer than the wild type fragment due to
the triplet insertion (Figure S2B). Exon 5 of the other dwarfs was
analyzed but none of these had the allele with the triplet insertion.
No other mutations were identified in the complete LHX3 cDNA
from the dwarfs, as expected from the genomic DNA sequence
analysis. The analysis of the complete cDNA corrected the
Genbank annotation of the gene and will be described elsewhere.
Discussion
Pituitary dwarfism in German shepherd dogs has been seen for
decades and dwarfs are born in purebred populations all over the
Figure 2. Structure of exon 5, intron 5, and exon 6 of canine LHX3. (A) The DNA sequence derived from BAC clone RP81-17A4 fills a gap in the
reference genome sequence build 2.1. The intron is indicated by bold characters and the putative splice branch site is underlined. The intron
contained 6 repeats of the 7 bp sequence GCGCCCC, indicated by alternating grey and black blocks. The G at position 3 of the third repeat was
mutated to a C and the last repeat ends with a G-residue. The Genbank accession number of the DNA sequence is Q913875. (B) Comparison of the
DNA sequence of intron 5 in the normal German shepherd dogs B4 and C8 and the dwarfs B3 and C6 after bisulfite treatment of genomic DNA. The
treatment converts unmethylated cytosine residues to uracil residues, which act like thymine in the PCR. The intron in the normal dogs B4 and C8
(Fig. S2) consisted of 75 bp and contained 6 repeats of the 7 bp sequence which are converted to GTGTTTT, indicated by alternating grey and black
blocks. Seven consecutive nucleotides in the region of repeats 4–6 are deleted from the intron of the dwarfs B3 and C6, indicated by dashes
(NM_001197187, c.622-37-31del).
doi:10.1371/journal.pone.0027940.g002
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was used to localize the genetic defect causing this disorder. The
stepwise approach was similar to that described by Leegwater et al.
[22]. In the first step, a limited number of DNA samples from two
informative families were typed with all markers. Candidate
regions were selected and ranked using loose criteria and analyzed
one by one in all available dogs. Fortunately, the marker
REN177B24 on chromosome 9 that ranked highest after the first
step turned out to be associated with dwarfism in the study group.
The followed strategy saved time and reduced expenses in
comparison with a screen of the marker set in the complete study
group.
The linkage of the REN177B24 region with the phenotype was
confirmed by analysis of closely spaced markers. The multipoint
lod score of 9.8 for linkage between the region on CFA09 and the
dwarfism phenotype indicated that the mutated gene is located in
this region. The critical region contained one gene of major
interest, i.e., LHX3 (also known as LIM-3 or P-Lim). LHX3 is a
member of the LIM homeodomain protein family of DNA-
binding transcription factors. These factors regulate the expression
of genes that pattern the body and are critical for cell
specialization during embryonic development [23]. Molecular
defects in the LHX3 gene are associated with the CPHD syndrome
in humans. Ten different homozygous LHX3 defects have been
reported in 24 human patients from consanguineous families [24–
28]. Most human patients display a complete deficit of all anterior
pituitary hormones, except for adrenocorticotropic hormone. In
mice, LHX3 is essential for differentiation and proliferation of
pituitary cell lineages [16]. Homozygous LHX3-knockout mice are
stillborn or die within 24 h of birth. Such mice display a complete
absence of the differentiated hormone secreting cells, except for
some corticotropes [16,17]. Because the endocrinological pheno-
type of humans with LHX3 mutations and LHX3-knockout mice is
consistent with the phenotype of the GSD dwarfs, we considered
LHX3 an excellent candidate gene for involvement in pituitary
dwarfism in this breed.
Figure 3. Defective splicing due to a deletion in intron 5 of canine LHX3 demonstrated by exon trapping. (A) Map of part of the
plasmids used for transfection of COS-7 cells. The open and closed boxes represent exons 5 and 6 of canine LHX3, as indicated. The hatched boxes
represent chimeric exons that consist of HIV-1 tat and rabbit HBB2 gene sequences. The double lines indicate vector sequences of pSPL3b [50]. The
recombinant DNA is transcribed from the SV40 promoter at the indicated position. The map is not drawn to scale. The horizontal arrows indicate the
positions of the PCR primer sets I and II that were used on cDNA derived from the cells. Primer set II was adapted to bisulfite treatment of the RNA.
The vertical arrow points out intron 5, consisting of 75 bp in the control and 68 bp in the mutant construct. (B,C) Eukaryotic COS-7 cells were
transfected with recombinant plasmids containing the control or the mutant intron 5 of canine LHX3. After 2 days, RNA was isolated and analyzed by
RT-PCR. The PCR products were analyzed by agarose gel electrophoresis in the presence of ethidium-bromide. The structure of the fragments was
obtained by DNA sequence analysis of bands excised from the gels. These structures are indicated by drawings as in (A). (B) The 7 bp deletion leads
to exon 5 skipping in a proportion of the transcripts. The products were analyzed with primer set I. Lane 1: size marker=100 bp ladder, * indicates
the 500 bp fragment; lane 2: products derived from cells transfected with plasmids containing intron 5 of 75 bp; lane 3: intron 5 of 68 bp; lanes 4 and
5: as lanes 2 and 3, respectively, except that reverse transcriptase was omitted to exclude contamination of RNA substrate with plasmid DNA; lane 6:
transfection with vector pSPL3b without insert; lane 7: no transfection. Primer set I does not amplify fragments containing intron 5 due to the high
cytosine content of the intron. (C) The 7 bp deletion leads to retention of intron 5 in a proportion of the transcripts. The RNA was treated with
bisulfite and analyzed with primer set II. Lanes 1 and 4: products derived from cells transfected with plasmids containing intron 5 of 75 bp; lanes 2
and 5: products derived from cells transfected with plasmids containing intron 5 of 68 bp; lane 6: transfection with vector pSPL3b without insert; lane
3: size marker=100 bp ladder, * indicates the 500 bp fragment. Lanes 4 and 5: omission of reverse transcriptase to exclude contamination of RNA
substrate with plasmid DNA.
doi:10.1371/journal.pone.0027940.g003
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associated with pituitary dwarfism of GSD. Analysis of intron 5
revealed a 7 bp deletion that was associated with defective splicing
of a proportion of the transcripts in vivo and in vitro. The aberrant
splicing products resulted from skipping of exon 5 or retention of
intron 5. Skipping of exon 5 results in a frame shift; the translation
product will lack the homeodomain and will therefore probably
not be functional [29]. Retention of the mutant intron of 68 nt
also leads to a frame shift in the part of the mRNA that codes for
the homeodomain. The splice donor, acceptor and putative
branch sites are not altered by the mutation and the deleted
sequence GCGCCCC is not similar to any known intronic splice
enhancer. Therefore, the splicing of the mutant intron 5 must be
hampered by a structural constraint such as its size.
Natural deletion mutants and in vitro experiments indicate that
there is a minimum size of 65–78 nt of introns in higher
eukaryotes [30–38]. It appears that a universal threshold of
minimal intron size cannot be defined (Table 1). In the case of
murine notch4 an intron of 68 nt is spliced normally, while a
mutant intron of 71 nt of human PKD1 with apparently normal
splicing signals is deleterious [33,35]. It seems plausible that
demands on intron size are dictated by requirements on spacing
between the donor and the branch site and between the branch
site and the splice acceptor [39–41]. The first reaction of splicing is
a nucleophilic attack of the branch site on the 59 splice donor,
resulting in lariat formation. The loop of the lariat is composed of
the fragment between the 59 donor and branch site. From known
deletion mutants and in vitro experiments it can be concluded that
Figure 4. Splicing products of LHX3 RNA in German shepherd dwarfs. (A) Normal splicing of intron 5 as well as retention of the intron was
observed in the pituitary of one of the dwarfs (F8). The cDNA fragments were generated with Platinum pfx polymerase and primers LHX3 ex4-7 F and
LHX3 intron5 R in exons 4 and 6, respectively (Table S4). The fragments were analyzed by agarose gel electrophoresis. Lane 1: 100 bp size standard,
* indicates the 500 bp fragment; lane 2: fragment derived from a control dog of mixed breed without the 7 bp deletion in intron 5 or other LHX3
mutations; lane 3: fragments derived from a dwarf homozygous for the deletion in intron 5; lanes 4 and 5: as lanes 2 and 3, respectively, without
reverse transcriptase. The structure of the fragments as indicated by the drawings was confirmed by DNA sequence analysis of the excised bands.
Open box: exon 5, closed box: exon 6, line: intron 5. (B) The cDNA sequence of the same dwarf, obtained with primers in exons 4 and 7 and standard
taq DNA polymerase, indicates that exon 5 was skipped in a proportion of the transcripts. (C) The other dwarf (F9) for which pituitary RNA was
available displayed heterozygosity for an insertion of an ACA trinucleotide sequence (underlined) in exon 5. This insertion translates into insertion of
an asparagine residue (underlined) in the amino acid sequence (bold).
doi:10.1371/journal.pone.0027940.g004
Table 1. Distance parameters of normal and defective introns.
Intron Intron size (nt) Donor-branch distance (nt)
Gene Gene ID number normal mutant normal mutant Reference
PKD1 5 3 1 0 4 37 55 75 23 43 2
PKD1 5 3 1 0 4 37 55 55 23 23 2
PKD1 5 3 1 0 3 19 07 16 74 83 3
RECQL4 9401 8 77 66 61 50 34
notch4 18132 10 68 60 50 42 35
GNPTG 84572 8 76 43 ? ? 38
SLC34A3 142680 9 167 66 145 44 36
SLC34A3 142680 10 139 54 77 - 36
SLC4A11 610206 7 87 68 63 42 37
recombinant 81 47 59 47 30
AdC E1A 2652980 114 78 86 49 39
LHX3 607584 5 75 68 53 46 this study
?=no clear branch site.
-=no branch site.
doi:10.1371/journal.pone.0027940.t001
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(Table 1). Like for total size, this threshold is not strict since a
distance of 50 nt is normal in mouse notch4 but deleterious in
human RECQL4. The overlap between normal and shortened
donor-branch site distances is slightly less than the overlap
between the sizes of complete and mutant introns, suggesting that
the first parameter better defines the size requirement. There is no
structural constraint to form an RNA lariat with a loop of 50 nt.
Steric hindrance of splicing factors probably impedes splicing if the
distance between the splice donor and branch site is too small [39].
The deletion in canine LHX3 shortened the distance between the
splice donor and branch site to 48 nt. It did not affect the RNA
sequence context of intron 5 because the deleted sequence is one of
the 6 direct tandem repeats normally present in the intron.
Therefore we can reliably conclude that steric parameters retard
the splicing of intron 5.
The size of intron 5 of LHX3 of mammals ranges from 75 nt in
dog and horse to 114 nt in cow (Table S1). The GC content of the
intron is invariably high, but the analyzed species other than dog
lack repetitive elements, reducing the chance of size alterations
during DNA replication. Therefore the risk of size reduction of the
intron, affecting expression of the gene, is probably low for these
species.
The splicing deficiency of the canine LHX3 intronic deletion in
the in vitro system was not absolute and accordingly we detected
wild type LHX3 mRNA in the two available pituitaries from
dwarfs. Possible variations in the level of residual activity between
dwarfs could be related to the high level of phenotypic variability
that we observe [10]. Because there was only one pituitary
available of a dwarf that was homozygous for the 7 bp deletion, we
could not adequately evaluate the expression level of LHX3 in
dwarfs. The qPCR experiment of the one sample indicated that
the LHX3 mRNA level is strongly reduced. This reduction is less
obvious from the comparison of the cDNA products of a dwarf
and a normal dog in Figure 4A. It should be noted however that
this experiment was not quantitative and only shows the endpoint
of the PCR. Similarly, the intensity of the two bands in lane 2 of
Figure 4A cannot be used for an quantitative assessment of the
level of intron retention because the fragment with the retained
intron is probably subject to nonsense mediated decay leading to
underrepresentation of the corresponding band.
Due to the high GC content of intron 5, we experienced
difficulties to amplify this intron by PCR. Bisulfite treatment, used
to convert cytosine bases to uracil, is known to resolve strong base-
pairing and allow the analysis of GC-rich DNA sequences. We
applied it in this study to modify cytosine rich RNA before cDNA
synthesis. To the best of our knowledge, this is the first report of
the application of bisulfite treatment of RNA to allow RT-PCR.
One of the dwarfs turned out to be a compound heterozygote
for an insertion of an ACA triplet in exon 5 and the repeat deletion
in intron 5 of LHX3. The insertion leads to duplication of an
asparagine residue in the first a-helix of the DNA-binding
homeodomain of the protein. Although in a number of vertebrates
the LHX3 protein does have two consecutive N-residues at the
position of this mutation, the insertion is still expected to demolish
the function of the homeodomain. This is because the spacing of
amino acids that contact the DNA binding site is critical and the
size of the domain is highly conserved [42]. A blast search of the
non-redundant protein database with human LHX3 shows that
the length of the homeodomain of all known vertebrate LHX1,
LHX2, LHX3 and LHX4 proteins is identical.
Fragment length analysis showed that the two mutations
occurred independently, i.e., that the triplet insertion was not a
secondary mutation in an allele of the LHX3 gene that was already
dysfunctional because of the 7 bp deletion. Apparently by
coincidence, this dwarf was homozygous for the same three
markers as all other dwarfs (Figure S1F). The detection of two
mutations in LHX3 supports our conclusion that this gene is
involved in the dwarfism phenotype in GSD, since the odds that
we would have detected two mutations in a strong positional
candidate gene by chance are negligible. The high frequency of
0.094 of the deletion allele in a group of Dutch GSDs is not
abnormal in pet genetics [43]. It warrants the implementation of a
DNA test to prevent mating of carriers and reduce the spread of
the disorder in the breed.
In this study, we have demonstrated that a contracted DNA
repeat in intron 5 of LHX3 could well be responsible for CPHD in
GSD by leading to aberrant splicing. Pituitary dwarfism in GSD
forms a natural model for experimental therapies of CPHD in
humans. One important requirement, identification of the
associated gene, has now been fulfilled.
Materials and Methods
Ethics Statement
The dogs entered in this study, presented to the University
Clinic for Companion Animals in Utrecht for diagnosis, treatment
and sometimes subsequent euthanasia for compassionate reasons,
were examined and handled by a licensed veterinarian (HSK).
Pituitary function tests were performed and blood samples were
collected in the course of routine diagnosis and care. All dogs were
privately owned and included with informed consent of the
owners. Thus we complied to the conditions set forth in the Dutch
‘Wet op de Uitoefening van de Diergeneeskunde’ (Law on the
Practice of Veterinary Medicine) of March 21, 1990 and approval
of an ethics committee for the use of samples of the animals was
not necessary.
Animals
The study group comprised 23 GSD with pituitary dwarfism, 9
of their healthy parents, 17 of their healthy siblings, 37 unrelated
GSD with normal growth and 1 healthy control dog of mixed
breed. There were two sibling pairs and one sibling trio of dwarfs
in the group of patients (Figure S1A, S1D and S1E). Three parents
produced dwarfs with different mates (Figure S1E). The diagnosis
of pituitary dwarfism was based on clinical manifestations and the
results of a combined anterior pituitary simulation test using four
releasing hormones, i.e., growth hormone-releasing hormone,
thyrotropin-releasing hormone, gonadotropin-releasing hormone,
and corticotropin-releasing hormone, according to methods
described previously [12,44,45]. Blood samples were collected
and genomic DNA was isolated from the samples by a salt
extraction method [46]. The origin and the birth year of each
dwarf and available related dogs is listed in Table S2).
Linkage analysis
A genome wide linkage analysis was performed with two
families of GSD in which three dwarfs were born, i.e., pedigrees A
and B (Figure S1A and S1B). The dwarfs (A7, A8, B3), parents
(A5, A6, B1, B2), and two healthy siblings (A9, A10) were
genotyped with 256 microsatellite markers listed in Table S3. The
microsatellite markers were selected from the 5000cR hybrid
radiation map and from the marker set derived thereof (Guyon
et al. 2003). The criteria for candidate regions in the genomic
DNA were that the dwarfs from pedigree A had to be homozygous
for the same allele of at least one marker from that region and that
the dwarf of pedigree B had to share at least one copy of this allele.
The candidate regions were ranked according to the information
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parents. The highest ranked regions were then further investigated
by typing the complete study group with the corresponding
markers. To fine-map the candidate regions, additional microsat-
ellites listed in Table S4 were selected from the reference canine
DNA sequence using Tandem Repeats Finder [47], after masking
of LINE and SINE elements with Repeatmasker (Smit et al. 1996).
The microsatellite markers were genotyped using standard PCR
techniques with oligonucleotides of which one was fluorescently
labeled at the 59-end with 6-FAM, TET, HEX, VIC, NED or
PET. The products were mixed with size standard 500GS
TAMRA or 500GS LIZ of Applied Biosystems (ABI) depending
on the oligonucleotide label and analyzed with a 3100 Genetic
Analyzer (ABI), using Genescan 3.1 software (ABI) for genotype
assessment.
Families A-E and data of markers CA7, REN256F13, CA5,
CA1, CA8, REN177B24, CA3 and FH2885 were used for
multipoint lod score calculation with Genehunter 2.1 software
[48]. We assumed a genetic distance of 1 cM per Mbp and the
observed alleles of each marker were assumed to have equal
frequencies. The calculation was based on a recessive inheritance
model with full penetrance and no phenocopies.
Characterization of LHX3
The RP81 BAC library was screened with a 1.1 kb PstI fragment
from mouseLHX3 cDNA asdescribed previously [49].TheDNAof
BAC 17A4 was isolated with the Hispeed plasmid isolation kit
(Qiagen). The intron 5-exon 6 junction was sequenced directly from
the BAC DNA with primers BAC17A4 F and BAC17A4 R (Table
S4) using BigDye v.3.1 and analyzed with an ABI 3100 Genetic
Analyzer, according to the protocols of the supplier.
The exons and intron-exon junctions of LHX3 were amplified
from genomic DNA of dwarfs and control dogs using standard
PCR techniques with the primers detailed in Table S4.
Genomic DNA that served as a template for PCR amplification
of intron 5 of canine LHX3 was treated with bisulfite and purified
with the EZ DNA methylation-gold kit (Zymo Research). The
DNA (100 ng) was mixed with buffer and bisulfite, denatured at
98uC for 10 min and incubated at 64uC for 2.5 h. The treated
DNA was purified as prescribed by the manufacturer. The PCR
reaction was set up to amplify the DNA molecule derived from the
strand with the coding sequences. The used primers were BS
LHX3 ex5 F and BS LHX3 ex6 R1 (Table S4). In case of
fragment analysis, the forward primer was labeled with 6-FAM
(Eurogentec) and the products were analyzed with the Genetic
Analyzer 3130xl and Genemapper 4.0 software, both from ABI. In
case of DNA sequence analysis, the PCR was performed using
standard protocols. The PCR products were purified with Shrimp
Alkaline Phosphatase (Promega) and Exonuclease I (New England
BioLabs), and used as a template in a DNA sequencing reaction
containing BigDye Terminator v3.1 (ABI), according to manu-
facturer’s instructions. The reaction products were purified with
multiscreen 96-well sephadex 50-gel filtration plates, and analyzed
on an ABI 3100 Genetic Analyzer (ABI).
The cDNA of LHX3 from two dwarfs (F8 and F9) and a control
dog of mixed breed was analyzed. Total RNA was obtained from
the anterior pituitary using the RNeasy mini kit (Qiagen) and
treated with DNaseI as recommended by the manufacturer. The
cDNA was synthesized with AMV Reverse Transcriptase
(Promega), using oligo-dT as primer. Overlapping fragments were
amplified with the primer pairs described in Table S4.
For the quantification of LHX3 mRNA, cDNA was synthesized
with the Iscript kit (Bio-Rad). Quantitative PCR was performed
with the IQ SYBR Green supermix (Bio-Rad) with primers LHX3
ex3-4 F, which overlapped exons 3 and 4, and LHX3 ex4 R
(Table S4) in exon 4 of LHX3, all according to the manufacturer’s
protocols. The annealing temperature was 68uC. The gene RPS5
was used as a reference with primers RPS5 F and RPS5 R (Table
S4) and the data was analyzed with MyiQ iCycler (Bio-Rad). The
RNA that was used for the qPCR experiment was isolated from
the anterior pituitary of the male dwarf F8, euthanized at an age of
11 months and from the normal male dog of mixed breed at the
age of 4 years.
The pituitary cDNA fragments that spanned intron 5 were
amplified with Platinum pfx DNA polymerase (Invitrogen) with
primers LHX3 intron5 F and LHX3 intron5 R (Table S4). The
hybridization temperature of the PCR was 64uC and the
elongation temperature was 68uC.
The DNA sequences were aligned using the Seqman program
from Lasergene software (DNASTAR) and compared to the
reference dog genome with BLAST software (www.ncbi.nlm.nih.
gov/BLAST). The Seqman program was also used to align the
cDNA sequences obtained from the dwarfs with those obtained
from the healthy control dog.
Splicing assay
The normal intron 5 of canine LHX3 was subcloned with the
neighboring exons 5 and 6 as a NotI-BamHI fragment of 1040 bp
from the canine BAC 17A4 in the plasmid pSPL3b. The NotI site
is located 43 bp upstream of exon 5 and the BamHI site is 597 bp
downstream of exon 6. The cloning site of pSPL3b is situated in
the HIV-1 tat intron flanked by the proper tat exon-intron
junctions. The transcription of the recombinant exons and introns
is under control of a SV40 promoter [50]. A mutant intron with
the deletion of the GSD dwarfs was constructed with the
recombinant plasmid as a PCR template, a phosphorylated
oligonucleotide of 82 nt spanning the mutant intron and a
phosphorylated oligonucleotide positioned adjacent to the first
primer in the opposite strand. The high fidelity Phusion
polymerase was used for this purpose under conditions recom-
mended by the supplier (New England Biolabs). The PCR
products were circularized with T4 DNA ligase and used to
transfect competent JM109 bacteria (Promega). The presence of
the mutation was confirmed by DNA sequence analysis.
The simian COS-7 cell line (6610
4 cells) was transfected using
Lipofectamin 2000, according to the protocol of the manufacturer
(Invitrogen). After growth for two days, the RNA was isolated from
the cells with the RNeasy Mini Kit (Qiagen) and treated two times
with DNase I. The iScript kit (Bio-Rad) was used to produce
cDNA with random primers. The RNA (500 ng) was modified
with bisulfite and purified in the same manner as DNA, except
that the initial denaturation step was 1 min at 98uC, followed by
incubation at 64uC for 30 min. The iScript kit (Bio-Rad) was used
to produce cDNA with random primers. The PCR primers to
amplify the region extending from the first, vector derived exon to
exon 6 of LHX3 without prior bisulfite treatment of the RNA were
pSPL3b F en LHX3 ex6 R (Fig. 3A, primer set I; Table S4). The
PCR primers to amplify the exon 5 – exon 6 region after bisulfite
modification were BS LHX3 ex5 F and BS LHX3 ex6 R2 (Fig. 3A,
primer set II; Table S4). In case of single reaction products,
the DNA fragment was sequenced directly as described above. In
case of multiple products, the bands were separated by electro-
phoresis on an agarose gel, excised, purified with the Qiaquick gel
extraction kit (Qiagen), and sequenced as described
above.
The positions of the putative branch site of normal and defective
introns from the literature were derived by comparison of the
Dog Dwarfism Associated with Shortened LHX3 Intron
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27940intron with a published U2-dependent branch site consensus
sequence [51].
Supporting Information
Figure S1 Cosegregation of pituitary dwarfism with a
region of canine chromosome CFA09 in German shep-
herd dwarfs. (A,B) A genome wide analysis was performed with
microsatellite markers of Table S1 and DNA of the dwarfs of litters
A and B, their parents and siblings A9 and A10. The genotypes of
marker REN177B24 were consistent with the presence of the gene
for dwarfism. Analysis of closely situated markers confirmed the
homozygosity by descent of the region in the dwarfs. (C–E) The
region was analyzed in other available families confirming the
cosegregation with dwarfism. (F) Nine isolated cases of pituitary
dwarfism also displayed homozygosity in the region. The region
between REN256F13 and REN177B24 was identically homozy-
gous in all dwarfs. The dwarf indicated F9 turned out to be a
compound heterozygote for two independent mutations. The
alleles associated with pituitary dwarfism are highlighted in green.
(PDF)
Figure S2 Demonstration of DNA mutations in genomic
DNA fragments of LHX3 in German shepherd dwarfs. (A)
Partial DNA sequence of exon 5 in dwarf F9 confirms
heterozygosity of a trinucleotide insertion (underlined) observed
in cDNA from the same dog. (B–D) The site of the insertion and
intron 5 are amplified together by PCR with a 6-FAM labeled
primer. (B) The normal German shepherd dog B4 displays a single
fragment of 240 bp. (C) All dwarfs except F9 are homozygous for
the 7 bp deletion in intron 5 as shown by a single fragment of
233 bp as for dwarf B3. (D) The dwarf F9 displays two alleles with
either the deletion or the insertion of 3 bp.
(PPT)
Table S1 Size and DNA sequence of intron 5 of LHX3 in
mammals.
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Table S2 Birth year, sex and origin of German shep-
herd dogs included in the study of pituitary dwarfism.
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Table S3 Genome wide set of microsatellite markers.
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Table S4 DNA sequences of oligonucleotides used in the
study of pituitary dwarfism.
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